Cantor Fitzgerald biotech analysts issued a rare and scathing note criticizing Health and Human Services Secretary Robert F. Kennedy Jr, according to Bloomberg. The note followed the abrupt resignation of FDA official Peter Marks. Analysts Josh Schimmer and Eric Schmidt urged the Trump administration to “re-evaluate” Kennedy’s leadership, saying he is steering the country “into dangerous territory” with views that undermine vaccine safety. The analysts described Marks’ ouster as a “clear condemnation” of HHS leadership and called for action, expressing confidence that the administration could course-correct.
